118 related articles for article (PubMed ID: 6682929)
1. Adriamycin, BCNU, and cyclophosphamide in drug-resistant adenocarcinoma of the ovary.
Presant CA; Bartolucci A
Med Pediatr Oncol; 1983; 11(3):151-3. PubMed ID: 6682929
[TBL] [Abstract][Full Text] [Related]
2. Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU, NSC 409962) and cyclophosphamide therapy of drug-resistant metastatic breast carcinoma.
Presant CA; Van Amburg A; Klahr C
Cancer; 1977 Sep; 40(3):987-93. PubMed ID: 902247
[TBL] [Abstract][Full Text] [Related]
3. Adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU-NSC 409462), and cyclophosphamide in refractory adenocarcinoma of the breast and other tumors.
Presant CA; Kolhouse JF; Klahr C
Cancer; 1976 Feb; 37(2):620-8. PubMed ID: 1253101
[TBL] [Abstract][Full Text] [Related]
4. Polychemotherapy in ovarian cancer: treatment with Adriamycin, BCNU and cyclophosphamide vs. Adriamycin and cyclophosphamide.
Mazzei T; Bonazza M; Amunni G; Scarselli G; Branconi F; Massi GB
Chemioterapia; 1984 Feb; 3(1):10-5. PubMed ID: 6535650
[TBL] [Abstract][Full Text] [Related]
5. A randomized comparison of melphalan versus melphalan plus hexamethylmelamine versus adriamycin plus cyclophosphamide in ovarian carcinoma.
Omura GA; Morrow CP; Blessing JA; Miller A; Buchsbaum HJ; Homesley HD; Leone L
Cancer; 1983 Mar; 51(5):783-9. PubMed ID: 6401594
[TBL] [Abstract][Full Text] [Related]
6. Adriamycin, 1,3-bis (2-chloroethyl) 1 nitrosourea (BCNU, NSC No. 409962), cyclophosphamide plus prednisone (ABC-P) in melphalanresistant multiple myeloma.
Presant CA; Klahr C
Cancer; 1978 Sep; 42(3):1222-7. PubMed ID: 698913
[TBL] [Abstract][Full Text] [Related]
7. Melphalan versus adriamycin in the treatment of advanced carcinoma of the ovary.
de Palo GM; de Lena M; Di Re F; Luciani L; Valagussa P; Bonadonna G
Surg Gynecol Obstet; 1975 Dec; 141(6):899-902. PubMed ID: 1103333
[TBL] [Abstract][Full Text] [Related]
8. Polychemotherapy with carmustine, cyclophosphamide plus adriamycin in the treatment of advanced ovarian cancer.
Facchini V; Gadducci A; Bogi G; Colombi L; Basile AG; Ballantini M; De Pasquale F; Fioretti P
Eur J Gynaecol Oncol; 1985; 6(1):37-40. PubMed ID: 4038650
[TBL] [Abstract][Full Text] [Related]
9. Advanced and recurrent carcinoma of the ovary treated with a combination of cyclophosphamide, doxorubicin, and cytosine arabinoside.
Jobson VW; Nordqvist SR; Averette HE
Gynecol Oncol; 1983 Apr; 15(2):154-9. PubMed ID: 6832631
[TBL] [Abstract][Full Text] [Related]
10. Six-drug chemotherapy (hexamethylmelamine, doxorubicin, cisplatin, cyclophosphamide, methotrexate, and 5-FU; CHAMP-5) for ovarian carcinoma: alternating sequences of combination regimens.
Pasmantier MW; Coleman M; Silver RT; Ballard WP
Cancer Treat Rep; 1985 Jun; 69(6):689-93. PubMed ID: 3926310
[TBL] [Abstract][Full Text] [Related]
11. Adriamycin, BCNU plus cyclophosphamide (ABC) in advanced carcinoma of the head and neck.
Presant CA; Ratkin G; Klahr C; Brown C
Cancer; 1979 Nov; 44(5):1571-5. PubMed ID: 227570
[TBL] [Abstract][Full Text] [Related]
12. Amphotericin B induction of sensitivity to adriamycin, 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) plus cyclophosphamide in human neoplasia.
Presant CA; Klahr C; Santala R
Ann Intern Med; 1977 Jan; 86(1):47-51. PubMed ID: 264783
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy with adriamycin-cyclophosphamide for advanced ovarian carcinoma.
Parker LM; Griffiths CT; Yankee RA; Canellos GP; Gelman R; Knapp RC; Richman CM; Tobias JS; Weiner RS; Frei E
Cancer; 1980 Aug; 46(4):669-74. PubMed ID: 7397632
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy of advanced prostatic cancer with adriamycin, BCNU, and cyclophosphamide.
Presant CA; Van Amburg A; Klahr C; Metter GE
Cancer; 1980 Dec; 46(11):2389-92. PubMed ID: 7438014
[TBL] [Abstract][Full Text] [Related]
15. Triple drug chemotherapy for advanced ovarian carcinoma: comparative study of two regimens.
Aroney RS; Levi JA; Dalley DN
Med J Aust; 1981 Jun; 1(12):633-5. PubMed ID: 7019638
[TBL] [Abstract][Full Text] [Related]
16. Combination chemotherapy of bronchogenic carcinoma with cyclophosphamide (NSC-26271) and BCNU (NSC-409962).
Curtis JE
Cancer Chemother Rep; 1974; 58(6):883-8. PubMed ID: 4614897
[No Abstract] [Full Text] [Related]
17. Feasibility study of combining metronidazole with chemotherapy.
Stewart DJ; Maroun JA; Young V; Crook AF; Hopkins HS; Yan RC; Richard MT; Hugenholtz H; Bélanger R; Heringer R
J Clin Oncol; 1983 Jan; 1(1):17-23. PubMed ID: 6422002
[TBL] [Abstract][Full Text] [Related]
18. HAC-Cytoxan (cyclophosphamide) chemotherapy for ovarian carcinoma. Alternating chemotherapy with intensification.
Coleman M; Pasmantier MW; Silver RT
Cancer; 1985 May; 55(10):2342-7. PubMed ID: 3921228
[TBL] [Abstract][Full Text] [Related]
19. 300 mg/m2 carboplatin (Cb), adriamycin (A) cyclophosphamide (C) (CACb-300) combination in advanced ovarian carcinoma: a feasibility study.
Martin P; Bugat R; Pinon G; Pinel MC; Heritier F; Chazard M; Delestrain MC; Belpomme D
Cancer Chemother Pharmacol; 1989; 23(5):331-2. PubMed ID: 2468426
[TBL] [Abstract][Full Text] [Related]
20. Phase II trial of sequential chemotherapy and low-dose radiotherapy in advanced gastric adenocarcinoma. A Southwest Oncology Group Pilot Study.
Bukowski RM; Theodors A; Purvis JD; Budd GT; Weick JK; Gahbauer R
Am J Clin Oncol; 1987 Oct; 10(5):376-9. PubMed ID: 3661488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
